As GM-CSF and G-CSF are also important chemotactic factors for tumor associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), we supposed that the significant changes of these two factors may affect the antitumor immunity which could cause the entirely different effects in 200 mg/kg SH-treated group. The gene discussed is CSF3; the disease is neoplasm.